File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Article: Effectiveness of Preprocedural Mouthwashes: A Triple-Blind Randomised Controlled Clinical Trial

TitleEffectiveness of Preprocedural Mouthwashes: A Triple-Blind Randomised Controlled Clinical Trial
Authors
KeywordsDentistry
Preprocedural mouthwash
Respiratory pathogens
SARS-CoV-2
Issue Date1-Jan-2024
PublisherWiley Open Access
Citation
International Dental Journal, 2024 How to Cite?
Abstract

Objectives: Bioaerosols generated during dental treatment are considered to be potentially carriers of infectious respiratory pathogens. The use of preprocedural mouthwashes has been suggested to reduce microbial load prior to dental surgery procedures. However, limited evidence on the effectiveness of preprocedural mouthwashes regarding mitigating respiratory pathogens exists. The aim of this clinical trial is to determine and compare the effectiveness of 3 preprocedural mouthwashes recommended by the Department of Health of the Hong Kong Special Administrative Region in the mitigation of respiratory pathogens during dental care in pandemic times.

Methods: In all, 228 participants were block-randomised to three groups based on preprocedural mouthwash used: povidone-iodine, hydrogen peroxide, and chlorhexidine digluconate. Participants, operators, and assessors were blinded to the assigned mouthwashes (triple-blind). Saliva was assessed for the presence of a number of respiratory pathogens (19 viruses including SARS-CoV-2). Changes in the prevalence and mean number of "any" pathogen present following mouthwash use were determined.

Results: Overall, the prevalence of any detected respiratory viral pathogens in the preprocedural saliva was 3.5% as compared to the postprocedural saliva: 1.3% (P = .034). The mean (SD) number of viruses was significantly lower following preprocedural mouthwash use, from 0.04 (0.18) to 0.01 (0.11) (P = .025). No significant differences were observed in the downward change (∆) of any detected virus (prevalence) (P = .155) or in the reduction of the mean number (∆) of any detected virus in the postprocedural saliva compared to preprocedural saliva of participants with respect to mouthwash used (P = .375).

Conclusions: The practice of using preprocedural mouthwash, as recommended by the government of Hong Kong, was effective in reducing the number of respiratory pathogens present during dental aerosol-generating treatment. This study lends support for official policy on use of preprocedural mouthwashes, which has significant implications for practice and policy during pandemics.


Persistent Identifierhttp://hdl.handle.net/10722/354691
ISSN
2023 Impact Factor: 3.2
2023 SCImago Journal Rankings: 0.803
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHuang, Shan-
dc.contributor.authorLeung, Yiu Yan-
dc.contributor.authorNeelakantan, Prasanna-
dc.contributor.authorChan, Kwok Hung-
dc.contributor.authorLeung, Joy Ka Yi-
dc.contributor.authorHung, Fan Ngai-
dc.contributor.authorMcGrath, Colman-
dc.date.accessioned2025-03-04T00:35:10Z-
dc.date.available2025-03-04T00:35:10Z-
dc.date.issued2024-01-01-
dc.identifier.citationInternational Dental Journal, 2024-
dc.identifier.issn0020-6539-
dc.identifier.urihttp://hdl.handle.net/10722/354691-
dc.description.abstract<p><strong>Objectives: </strong>Bioaerosols generated during dental treatment are considered to be potentially carriers of infectious respiratory pathogens. The use of preprocedural mouthwashes has been suggested to reduce microbial load prior to dental surgery procedures. However, limited evidence on the effectiveness of preprocedural mouthwashes regarding mitigating respiratory pathogens exists. The aim of this clinical trial is to determine and compare the effectiveness of 3 preprocedural mouthwashes recommended by the Department of Health of the Hong Kong Special Administrative Region in the mitigation of respiratory pathogens during dental care in pandemic times.</p><p><strong>Methods: </strong>In all, 228 participants were block-randomised to three groups based on preprocedural mouthwash used: povidone-iodine, hydrogen peroxide, and chlorhexidine digluconate. Participants, operators, and assessors were blinded to the assigned mouthwashes (triple-blind). Saliva was assessed for the presence of a number of respiratory pathogens (19 viruses including SARS-CoV-2). Changes in the prevalence and mean number of "any" pathogen present following mouthwash use were determined.</p><p><strong>Results: </strong>Overall, the prevalence of any detected respiratory viral pathogens in the preprocedural saliva was 3.5% as compared to the postprocedural saliva: 1.3% (P = .034). The mean (SD) number of viruses was significantly lower following preprocedural mouthwash use, from 0.04 (0.18) to 0.01 (0.11) (P = .025). No significant differences were observed in the downward change (∆) of any detected virus (prevalence) (P = .155) or in the reduction of the mean number (∆) of any detected virus in the postprocedural saliva compared to preprocedural saliva of participants with respect to mouthwash used (P = .375).</p><p><strong>Conclusions: </strong>The practice of using preprocedural mouthwash, as recommended by the government of Hong Kong, was effective in reducing the number of respiratory pathogens present during dental aerosol-generating treatment. This study lends support for official policy on use of preprocedural mouthwashes, which has significant implications for practice and policy during pandemics.</p>-
dc.languageeng-
dc.publisherWiley Open Access-
dc.relation.ispartofInternational Dental Journal-
dc.subjectDentistry-
dc.subjectPreprocedural mouthwash-
dc.subjectRespiratory pathogens-
dc.subjectSARS-CoV-2-
dc.titleEffectiveness of Preprocedural Mouthwashes: A Triple-Blind Randomised Controlled Clinical Trial-
dc.typeArticle-
dc.identifier.doi10.1016/j.identj.2024.08.017-
dc.identifier.scopuseid_2-s2.0-85205534834-
dc.identifier.eissn1875-595X-
dc.identifier.isiWOS:001467206000001-
dc.identifier.issnl0020-6539-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats